Canurta Inc. is a botanical biotechnology company developing an integrated platform for adaptive medicine. Through Canurta Therapeutics, Canurta Naturals, and its proprietary PolyKye AI discovery platform, the company connects botanical research, therapeutic development, manufacturing, and consumer health commercialization. This approach aims to translate complex molecular science into innovative health products and a pipeline of personalized botanical therapeutics.

Canurta began in 2021 with the formation of Canurta Therapeutics. Since then, the company has expanded its operations to include Canurta Therapeutics, Canurta Naturals, and the PolyKye AI discovery platform, bringing together scientific research, therapeutic development, and consumer health commercialization under Canurta Inc.

Canurta Inc. is headquartered in Canada, with research, corporate governance, and strategic operations based in the country. The company also maintains a presence in the United States through Canurta Naturals, supporting botanical ingredient manufacturing, consumer health product development, and commercialization.

CanurtaX operates under Canurta Limited Partnership (Canurta LP), a Canadian-controlled partnership that consolidates subsidiaries, IP, data assets, and treasury operations.

Vision: To advance a future where botanical science, artificial intelligence, and personalized medicine converge to improve human health through continuous discovery, innovation, and learning.Mission: To build an integrated biotechnology platform that transforms complex molecular science into innovative consumer health products and botanical therapeutics. By connecting research, AI-driven discovery, manufacturing, and real-world insights, Canurta aims to accelerate the development of evidence-based health solutions that evolve with individual needs.